Major depressive disorder

By Christian Otte, Stefan M. Gold, B. W. Penninx, C. Pariante, Amit Etkin, Maurizio Fava, David C. Mohr, A. Schatzberg. Nature Reviews Disease Primers, 2016

746 citations recorded by the source corpus.

Subfields: Behavioral Neuroscience, Biological Psychiatry, Pharmacology

View Paper: https://www.semanticscholar.org/paper/bd0c48ac0ff0338a7881bbd41c04f3f966283b26

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Gabriela de Oliveira Silveira
2. F. Palhano-Fontes
3. S. Mota-Rolim
4. F. Santos
5. Antonio A Silva-Junior
6. M. Wada
7. J. Riba
8. F. Osório

Citations in the corpus

• Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (2018, background): “We recently found that a single ayahuasca session in patients with depression increases blood flow in brain regions consistently implicated in the regulation of mood and emotions, such as the left nucleus accumbens, right insula and left subgenual area (Otte et al. , 2016; Sanches et al. , 2016).”
• Development of Artificial Intelligence for Determining Major Depressive Disorder Based on Resting-State EEG and Single-Pulse Transcranial Magnetic Stimulation-Evoked EEG Indices (2024, background): “The interview includes a medical history; family history; social history, including education and employment history, preferences, hobbies and habits; and drug use history along with psychiatric symptoms [3].”